Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
148 hedge funds and large institutions have $545M invested in Momenta Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 34 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 41
38% more call options, than puts
Call options by funds: $1.59M | Put options by funds: $1.15M
10% less funds holding
Funds holding: 164 → 148 (-16)
39% less capital invested
Capital invested by funds: $895M → $545M (-$351M)
47% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$8.9M |
| 2 |
SAM
Senzar Asset Management
New York
|
+$7.08M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$5.26M |
| 4 |
Renaissance Technologies
New York
|
+$5.15M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$17.1M |
| 2 |
TAM
Tocqueville Asset Management
New York
|
-$9.39M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$6.74M |
| 4 |
MHAM
Monroe Hall Asset Management
New York
|
-$5.45M |
| 5 |
Millennium Management
New York
|
-$4.3M |
MNTA Hedge Fund Activity: Q1 2016 in Review
148 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q1 2016, worth a combined $545M — down 39% from $895M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of MNTA and 18 opened new positions — a net loss of 16 holders — while 41 trimmed existing stakes and 59 added.
The largest buyer was Apex Capital Management, adding an estimated $8.9M. The largest seller was Capital World Investors, exiting entirely with an estimated $17.1M sold.
- 148 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q1 2016, down from 164 in Q4 2015.
- Funds reported $545M of Momenta Pharmaceuticals, Inc. stock for Q1 2016, down 39% quarter-over-quarter.
- 18 funds opened new Momenta Pharmaceuticals, Inc. positions in Q1 2016 and 34 closed out, a net change of -16 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q1 2016 was Apex Capital Management, an estimated $8.9M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q1 2016 was Capital World Investors, an estimated $17.1M sold.
Based on aggregated 13F filings for Q1 2016.